FI852516L - Anordning foer dosering av tillvaext befraemjande aemnen. - Google Patents
Anordning foer dosering av tillvaext befraemjande aemnen.Info
- Publication number
- FI852516L FI852516L FI852516A FI852516A FI852516L FI 852516 L FI852516 L FI 852516L FI 852516 A FI852516 A FI 852516A FI 852516 A FI852516 A FI 852516A FI 852516 L FI852516 L FI 852516L
- Authority
- FI
- Finland
- Prior art keywords
- tillvaext
- befraemjande
- dosering
- aemnen
- anording
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/626,400 US4747825A (en) | 1984-06-29 | 1984-06-29 | Apparatus and methodology for pulsed administration of growth promoting agents |
Publications (2)
Publication Number | Publication Date |
---|---|
FI852516A0 FI852516A0 (fi) | 1985-06-26 |
FI852516L true FI852516L (fi) | 1985-12-30 |
Family
ID=24510242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI852516A FI852516L (fi) | 1984-06-29 | 1985-06-26 | Anordning foer dosering av tillvaext befraemjande aemnen. |
Country Status (16)
Country | Link |
---|---|
US (1) | US4747825A (pt) |
EP (1) | EP0190199A4 (pt) |
JP (1) | JPS61502519A (pt) |
AU (1) | AU4605385A (pt) |
BE (1) | BE902783A (pt) |
BR (1) | BR8506785A (pt) |
DK (1) | DK294685A (pt) |
FI (1) | FI852516L (pt) |
IL (1) | IL75671A0 (pt) |
MW (1) | MW686A1 (pt) |
NO (1) | NO852603L (pt) |
OA (1) | OA08214A (pt) |
PT (1) | PT80738B (pt) |
RO (1) | RO95012A (pt) |
WO (1) | WO1986000233A1 (pt) |
ZA (1) | ZA854916B (pt) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089472A (en) * | 1988-01-26 | 1992-02-18 | Laboratorios Serono S.A. | Use of growth hormone releasing factor for improving mental function |
US5065748A (en) * | 1989-11-14 | 1991-11-19 | University Of South Florida | Method of diagnosing growth hormone disorders employing somatostatin and growth hormone releasing hormone |
US5065747A (en) * | 1989-11-21 | 1991-11-19 | University Of South Florida | Method for improving the accuracy of diagnosis of growth hormone deficiency |
US5428013A (en) * | 1991-01-04 | 1995-06-27 | Mugica; Jesus D. | Differential diagnosis and treatment of the states of growth hormone insufficiency (or deficiency) with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
US7910624B1 (en) | 1995-03-03 | 2011-03-22 | The Trustees Of Boston University | Compositions for the treatment of blood disorders |
JP3971454B2 (ja) * | 1993-10-29 | 2007-09-05 | ザ トラスティーズ オブ ボストン ユニバーシティ | 抗新生物剤としての酪酸、酪酸塩、および誘導体の生理学的に安定な組成物 |
EP0800405A4 (en) * | 1994-12-19 | 1998-11-11 | Beth Israel Hospital | CONTINUOUS ADMINISTRATION OF LOW DOSES OF HORMONE PARATHYRO DIENNE OR ITS AGONIST |
US6403647B1 (en) | 1996-07-26 | 2002-06-11 | Susan P. Perrine | Pulsed administration of compositions for the treatment of blood disorders |
EP2298350A3 (en) | 1996-07-26 | 2011-06-08 | Susan P. Perrine | Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders |
US5939456A (en) * | 1996-07-26 | 1999-08-17 | Perrine; Susan P. | Pulsed administration of compositions for the treatment of blood disorders |
ES2146530B1 (es) * | 1997-12-26 | 2001-04-16 | Consejo Superior Investigacion | Utilizacion del factor de crecimiento igf-i en la fabricacion de composiciones utiles en el tratamiento de la ataxia cerebelar. |
CA2324426A1 (en) * | 1998-02-11 | 1999-08-19 | Douglas V. Faller | Compositions and methods for the treatment of cystic fibrosis |
CA2498319A1 (en) * | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
US7998930B2 (en) | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
WO2010105112A1 (en) * | 2009-03-11 | 2010-09-16 | Hemaquest Pharmaceuticals, Inc. | Detection of short-chain fatty acids in biological samples |
US20130017188A1 (en) | 2009-07-31 | 2013-01-17 | The Brigham And Women's Hospital, Inc. | Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
WO2011038224A1 (en) | 2009-09-24 | 2011-03-31 | Trustees Of Boston University | Methods for treating viral disorders |
CN102802412A (zh) | 2009-12-08 | 2012-11-28 | 海玛奎斯特医药公司 | 用于治疗红细胞病症的方法及低剂量方案 |
US20110245154A1 (en) | 2010-03-11 | 2011-10-06 | Hemaquest Pharmaceuticals, Inc. | Methods and Compositions for Treating Viral or Virally-Induced Conditions |
US9428565B2 (en) | 2011-01-31 | 2016-08-30 | The General Hospital Corporation | Treatment and bioluminescent visualization using multimodal TRAIL molecules |
CA2830069C (en) | 2011-03-20 | 2019-11-12 | The University Of British Columbia | Therapeutic agent for emphysema and copd |
US9480696B2 (en) | 2011-05-04 | 2016-11-01 | Trustees Of Boston University | Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria |
US20140227293A1 (en) | 2011-06-30 | 2014-08-14 | Trustees Of Boston University | Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
US20140271657A1 (en) | 2011-10-12 | 2014-09-18 | Children's Medical Center Corporation | Combinatorial compositions and methods of treating hemoglobinopathies |
US9243037B2 (en) | 2011-11-10 | 2016-01-26 | Trustees Of Boston College | Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity |
WO2013082275A1 (en) | 2011-11-30 | 2013-06-06 | Trustees Of Boston College | Inhibitors of phosphodiesterases 11 (pde11) and methods of use to elevate cortisol production |
JP2015525781A (ja) | 2012-07-31 | 2015-09-07 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドThe Brigham and Women’s Hospital, Inc. | 免疫応答の調節 |
EP2890720B1 (en) | 2012-08-30 | 2019-07-17 | The General Hospital Corporation | Compositions and methods for treating cancer |
CA2887528C (en) | 2012-10-12 | 2023-08-29 | The Brigham And Women's Hospital, Inc. | Enhancement of the immune response |
US20150366890A1 (en) | 2013-02-25 | 2015-12-24 | Trustees Of Boston University | Compositions and methods for treating fungal infections |
EP3036226B1 (en) | 2013-08-22 | 2020-01-08 | The General Hospital Corporation | Inhibitors of human 12/15-lipoxygenase |
WO2015031765A2 (en) | 2013-08-29 | 2015-03-05 | Trustees Of Boston University | Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections |
CA2966352A1 (en) | 2013-11-26 | 2015-06-04 | The Brigham And Women's Hospital, Inc. | Compositions and methods for modulating an immune response |
WO2015089321A2 (en) | 2013-12-11 | 2015-06-18 | The General Hospital Corporation | Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation |
US20170107300A1 (en) | 2014-03-21 | 2017-04-20 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring |
AU2015249666A1 (en) | 2014-04-25 | 2016-11-17 | The Brigham And Women's Hospital, Inc. | Compositions and methods for treating subjects with immune-mediated diseases |
CA2983794A1 (en) | 2014-04-25 | 2015-10-29 | The Brigham And Women's Hospital, Inc. | Methods to manipulate alpha-fetoprotein (afp) |
JP7095990B2 (ja) | 2014-09-18 | 2022-07-05 | シーダーズ-サイナイ メディカル センター | 線維症を治療するための組成物及び方法 |
GB2557389B (en) | 2015-01-14 | 2020-12-23 | Brigham & Womens Hospital Inc | Treatment of cancer with anti-lap monoclonal antibodies |
WO2016172479A1 (en) | 2015-04-22 | 2016-10-27 | Cedars-Sinai Medical Center | Enterically delivered bitter oligopeptides for the treatment for type 2 diabetes |
WO2016196664A1 (en) | 2015-06-01 | 2016-12-08 | Cedars-Sinai Medical Center | Methods and use of compounds that bind to rela of nf-kb |
US20180185345A1 (en) | 2015-06-19 | 2018-07-05 | Trustees Of Boston University | Methods and compositions for treating herpesvirus induced conditions |
BR112018001441A2 (pt) | 2015-07-28 | 2018-09-11 | Vyome Biosciences Pvt Ltd | antibacterianos terapêuticos e profiláticos |
US10702586B2 (en) | 2015-09-28 | 2020-07-07 | Children's Hospital Los Angeles | Methods for treating diseases mediated by ErbB4-positive pro-inflammatory macrophages |
WO2017069958A2 (en) | 2015-10-09 | 2017-04-27 | The Brigham And Women's Hospital, Inc. | Modulation of novel immune checkpoint targets |
US20200016202A1 (en) | 2016-10-07 | 2020-01-16 | The Brigham And Women's Hospital, Inc. | Modulation of novel immune checkpoint targets |
CA3090322A1 (en) | 2018-02-12 | 2019-08-15 | Diabetes-Free, Inc. | Improved antagonistic anti-human cd40 monoclonal antibodies |
WO2020102454A1 (en) | 2018-11-13 | 2020-05-22 | Regents Of The University Of Minnesota | Cd40 targeted peptides and uses thereof |
CN114206447A (zh) | 2019-05-31 | 2022-03-18 | 维拉克塔附属公司 | 用组蛋白脱乙酰基酶抑制剂治疗病毒相关的癌症的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3498228A (en) * | 1967-05-01 | 1970-03-03 | Charles A Blumle | Portable infusion pump |
US3559644A (en) * | 1967-12-14 | 1971-02-02 | Robert F Shaw | Liquid infusion apparatus |
US3809871A (en) * | 1972-12-01 | 1974-05-07 | Nasa | Programmable physiological infusion |
US4273122A (en) * | 1976-11-12 | 1981-06-16 | Whitney Douglass G | Self contained powered injection system |
US4313439A (en) * | 1980-03-24 | 1982-02-02 | Biotek, Inc. | Automated, spring-powered medicament infusion system |
DE3015777A1 (de) * | 1980-04-24 | 1981-10-29 | Ferring Arzneimittel Gmbh, 2300 Kiel | Vorrichtung zur intermittierenden pulsatorischen applikation von fluessigen arzneimitteln |
US4306553A (en) * | 1980-07-22 | 1981-12-22 | The Regents Of The University Of Minnesota | Method of maintaining the fluidity of hormone solutions for parenteral administration |
US4517181A (en) * | 1982-09-15 | 1985-05-14 | The Salk Institute For Biological Studies | Mammalian PGRF |
US4529595A (en) * | 1983-01-13 | 1985-07-16 | The Salk Institute For Biological Studies | GRF Analogs |
-
1984
- 1984-06-29 US US06/626,400 patent/US4747825A/en not_active Expired - Lifetime
-
1985
- 1985-06-26 FI FI852516A patent/FI852516L/fi not_active Application Discontinuation
- 1985-06-27 BR BR8506785A patent/BR8506785A/pt unknown
- 1985-06-27 AU AU46053/85A patent/AU4605385A/en not_active Abandoned
- 1985-06-27 JP JP60503052A patent/JPS61502519A/ja active Pending
- 1985-06-27 WO PCT/US1985/001229 patent/WO1986000233A1/en not_active Application Discontinuation
- 1985-06-27 EP EP19850903566 patent/EP0190199A4/en not_active Withdrawn
- 1985-06-28 PT PT80738A patent/PT80738B/pt unknown
- 1985-06-28 NO NO852603A patent/NO852603L/no unknown
- 1985-06-28 IL IL75671A patent/IL75671A0/xx unknown
- 1985-06-28 BE BE0/215282A patent/BE902783A/fr not_active IP Right Cessation
- 1985-06-28 DK DK294685A patent/DK294685A/da not_active Application Discontinuation
- 1985-06-28 ZA ZA854916A patent/ZA854916B/xx unknown
-
1986
- 1986-01-31 MW MW6/86A patent/MW686A1/xx unknown
- 1986-02-27 RO RO86122377A patent/RO95012A/ro unknown
- 1986-02-28 OA OA58797A patent/OA08214A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BE902783A (fr) | 1985-10-16 |
PT80738A (en) | 1985-07-01 |
EP0190199A4 (en) | 1987-12-01 |
BR8506785A (pt) | 1986-11-25 |
US4747825A (en) | 1988-05-31 |
MW686A1 (en) | 1987-03-11 |
FI852516A0 (fi) | 1985-06-26 |
AU4605385A (en) | 1986-01-24 |
WO1986000233A1 (en) | 1986-01-16 |
ZA854916B (en) | 1986-02-26 |
DK294685D0 (da) | 1985-06-28 |
RO95012A (ro) | 1988-09-15 |
PT80738B (en) | 1986-12-11 |
IL75671A0 (en) | 1985-10-31 |
DK294685A (da) | 1985-12-30 |
NO852603L (no) | 1985-12-30 |
JPS61502519A (ja) | 1986-11-06 |
EP0190199A1 (en) | 1986-08-13 |
OA08214A (en) | 1987-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI852516L (fi) | Anordning foer dosering av tillvaext befraemjande aemnen. | |
FI852265A0 (fi) | Anordning foer oskillerande lineardrift av konstruktionsdelar. | |
FI861843A0 (fi) | Drivanordning foer borrstaong speciellt foer utfoerande av kontinuerlig djupborrning. | |
FI844046L (fi) | Foerfarande foer framstaellning av polytriaziner fraon aromatiska polycyanater. | |
FI862231A0 (fi) | Anordning foer utkastning av spelbollar. | |
FI83882B (fi) | Foerfarande foer framstaellning av blodlevring haemmande proteiner. | |
FI842544A0 (fi) | Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid. | |
FI864365A0 (fi) | Anordning foer spaonskaerande behandling av traedstammars sidor. | |
FI80896B (fi) | Foerfarande foer framstaellning av fenolskum. | |
FI853050L (fi) | Foerfarande foer framstaellning av farmaceutiskt aktiva kinolonkarboxylsyraderivat. | |
FI852552A0 (fi) | Foerfarande foer framstaellning av l-fenylalanin. | |
FI862439A (fi) | Foerfarande foer framstaellning av cellulosamassa. | |
FI851520L (fi) | Anordning foer sammanpressning av en blaosfolieslang. | |
FI852437A0 (fi) | Anordning foer framstaellning av tomografiroentgenbilder. | |
FI844493A0 (fi) | Realtidsproevning av byggnaders vaederbeteende. | |
FI850187L (fi) | Anlaeggning foer framstaellning av formsten av skumbetong. | |
FI850226A0 (fi) | Foerfarande foer framstaellning av leukotrienantagonister. | |
FI850758A0 (fi) | Foerfarande foer framstaellning av 3-metyl-7-fluor-5-nitrobenzotiofen. | |
FI852871L (fi) | Foerfarande foer framstaellning av kompositioner. | |
FI881266A0 (fi) | Anordning foer belysning av flaggor. | |
FI845082A0 (fi) | Anordning foer rengoerning av skor. | |
FI841919A0 (fi) | Anordning foer roerande av arbetsmaskins bomraecka. | |
FI842003A (fi) | Anordning foer dragande av skidspaor. | |
FI842102A0 (fi) | Anordning foer foerhindrande av ljusbaogeskador. | |
FI842673A0 (fi) | Anordning speciellt foer behandling av avfallsvatten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |
Owner name: THORNER, MICHAEL M. Owner name: LINKIE, DANIEL M. |